http://ip.law360.com/ The Newswire for Legal Professionals Copyright 2009 Portfolio Media, Inc. en-US http://ip.law360.com/images/headings/logo.gif http://ip.law360.com/ http://ip.law360.com/articles/135485 Aloft Media LLC has dismissed Oracle Corp. from a patent infringement suit that targets several leading financial products companies over their software, less than two weeks after the patent-holding company asserted a second patent in the suit. http://ip.law360.com/articles/135485 http://ip.law360.com/articles/135424 The U.S. International Trade Commission has effectively signed off on settlements between Cognex Corp. and respondents Yxlon International Inc. and Multitest Electronic Systems Inc., paving the way for the companies to resolve their infringement dispute over patents for machine vision software. http://ip.law360.com/articles/135424 http://ip.law360.com/articles/135491 Aurora World Inc. is seeking a preliminary injunction against Ty Inc., the maker of Beanie Babies, arguing that the plush toy giant is trying to piggyback off the success of Aurora's YooHoo & Friends line of toys by introducing an identical and infringing product. http://ip.law360.com/articles/135491 http://ip.law360.com/articles/135427 MvuInvestors LLC has appealed its recent loss to General Electric Co. unit GE Healthcare in their dispute over GE’s aborted deal to acquire Mvu’s MRI technology. http://ip.law360.com/articles/135427 http://ip.law360.com/articles/135447 The U.S. International Trade Commission has agreed to extend its target date for completion of an investigation into whether variable-speed wind turbine parts imported by Mitsubishi Heavy Industries Ltd. infringe two General Electric Co. patents. http://ip.law360.com/articles/135447 http://ip.law360.com/articles/135395 Teva Pharmaceuticals USA Inc., having come out on the losing end in a three-year infringement struggle with Alcon Inc. over a patent related to the anti-bacterial eye drop drug Vigamox, has said it will keep up the fight in an appeal to the U.S. Court of Appeals for the Federal Circuit. http://ip.law360.com/articles/135395 http://ip.law360.com/articles/135389 Exela PharmSci Pvt. Ltd. wants a federal appeals court to review a decision that the India-based drugmaker's proposed generic version of Allergan Inc.’s glaucoma treatment Alphagan infringed a patent. http://ip.law360.com/articles/135389 http://ip.law360.com/articles/135327 A federal judge has denied oil field services company Davis-Lynch Inc.’s request to throw out rival Weatherford International Inc.’s inequitable conduct defense in a patent infringement suit over oil and gas drilling technology. http://ip.law360.com/articles/135327 http://ip.law360.com/articles/135386 Business and intellectual property trial lawyer Timothy G. Barber, formerly head of the patent litigation team at Womble Carlyle Sandridge & Rice PLLC, has joined King & Spalding LLP as a partner in the firm’s Charlotte, N.C., office. http://ip.law360.com/articles/135386 http://ip.law360.com/articles/135336 A federal judge granted preliminary approval Thursday to a revised settlement among Google Inc., the Authors Guild Inc. and publishers that governs the use of copyrighted works displayed on the Google Books online library. http://ip.law360.com/articles/135336 http://ip.law360.com/articles/135318 A federal appeals court on Thursday struck down infringement claims for a bodybuilding supplement patent held by Iovate Health Sciences Inc. and the University of Florida Research Foundation, ruling that certain fitness magazine ads describing the product had rendered the patent obvious. http://ip.law360.com/articles/135318 http://ip.law360.com/articles/135349 A unit of St. Jude Medical Inc. has won a preliminary injunction against a former employee who allegedly stole trade secrets in order to set up a rival medical device company in China, according to attorneys representing St. Jude. http://ip.law360.com/articles/135349 http://ip.law360.com/articles/135307 A jury has sided with Novartis AG in a suit it filed claiming Teva Pharmaceuticals USA Inc. infringed the patent for its genital herpes drug Famvir by seeking regulatory approval to market its own generic version. http://ip.law360.com/articles/135307 http://ip.law360.com/articles/135312 Sony Corp., Panasonic Corp. and LG Electronics Inc. are among a slew of companies that have been accused by VoxPath RS LLC of infringing a patent for optical data storage technology. http://ip.law360.com/articles/135312 http://ip.law360.com/articles/135095 JPMorgan Chase & Co. has struck a partial settlement with Affiliated Computer Services Inc. in its patent infringement case over debit card services and check-imaging technology used to process child support payments. http://ip.law360.com/articles/135095 http://ip.law360.com/articles/135105 Twentieth Century Fox Home Entertainment LLC has lashed out at Redbox Automated Retail LLC's bid to keep its copyright and antitrust allegations in the Delaware court that is currently hearing Redbox's suits against two other studios, saying Redbox can't connect the dots between its allegations and the Delaware jurisdiction. http://ip.law360.com/articles/135105 http://ip.law360.com/articles/135067 Intellectual property lawyer Paul Garrity has joined Sheppard Mullin Richter & Hampton LLP from Kelley Drye & Warren LLP. http://ip.law360.com/articles/135067 http://ip.law360.com/articles/135221 Target Corp. has fired back at Coach Services Inc. in a suit accusing the retail giant of selling bags that reproduce or are confusingly similar to Coach's Ergo and signature patchwork designs. http://ip.law360.com/articles/135221 http://ip.law360.com/articles/135149 Athena Diagnostics Inc., the sublicensee of patents related to genetic tests for the detection and diagnosis of certain forms of diabetes, has accused rival laboratory Ambry Genetics Corp. of infringing four of those patents in its testing. http://ip.law360.com/articles/135149 http://ip.law360.com/articles/135185 The head of the European Commission's pharmaceutical task force reportedly told drug companies Thursday of plans to ask for details on patent deals with generic-drug makers that are suspected of delaying the entry of cheaper drugs into the market. http://ip.law360.com/articles/135185